Junichi Kitagawa

570 total citations
34 papers, 383 citations indexed

About

Junichi Kitagawa is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Junichi Kitagawa has authored 34 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Junichi Kitagawa's work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (6 papers) and Tryptophan and brain disorders (6 papers). Junichi Kitagawa is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (6 papers) and Tryptophan and brain disorders (6 papers). Junichi Kitagawa collaborates with scholars based in Japan. Junichi Kitagawa's co-authors include Hisashi Tsurumi, Takeshi Hara, Masahito Shimizu, Nobuhiro Kanemura, Nobuhiko Nakamura, Hiroshi Nakamura, Hisataka Moriwaki, Takuro Matsumoto, Naoe Goto and Soranobu Ninomiya and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Junichi Kitagawa

28 papers receiving 379 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Junichi Kitagawa 137 115 87 79 56 34 383
Katarzyna Brzeźniakiewicz‐Janus 40 0.3× 36 0.3× 21 0.2× 181 2.3× 152 2.7× 36 430
Cemal Beş 31 0.2× 46 0.4× 66 0.8× 72 0.9× 99 1.8× 68 464
Kenta Kambara 165 1.2× 107 0.9× 10 0.1× 70 0.9× 96 1.7× 35 448
G. Galaktidou 83 0.6× 15 0.1× 72 0.8× 85 1.1× 37 0.7× 30 487
Joanna Sulicka‐Grodzicka 39 0.3× 27 0.2× 14 0.2× 57 0.7× 97 1.7× 28 291
Luca Riva 85 0.6× 78 0.7× 44 0.5× 73 0.9× 8 0.1× 33 484
Tomoka Ao 34 0.2× 36 0.3× 136 1.6× 99 1.3× 80 1.4× 7 362
Almudena López‐Sampalo 18 0.1× 50 0.4× 49 0.6× 53 0.7× 130 2.3× 29 360
Koushi Yokomura 49 0.4× 86 0.7× 40 0.5× 44 0.6× 94 1.7× 18 352
Jenny Valentina Garmendia 22 0.2× 73 0.6× 27 0.3× 46 0.6× 101 1.8× 41 309

Countries citing papers authored by Junichi Kitagawa

Since Specialization
Citations

This map shows the geographic impact of Junichi Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Kitagawa more than expected).

Fields of papers citing papers by Junichi Kitagawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Kitagawa. The network helps show where Junichi Kitagawa may publish in the future.

Co-authorship network of co-authors of Junichi Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Kitagawa. A scholar is included among the top collaborators of Junichi Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Kitagawa. Junichi Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Nobuhiko, Nobuhiro Kanemura, Takuro Matsumoto, et al.. (2024). Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Nutrients. 16(16). 2653–2653.
2.
Nakamura, Nobuhiko, Kenji Fukuno, Shin Lee, et al.. (2024). Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine. SHILAP Revista de lepidopterología. 16(1). 114–124.
3.
4.
Kanemura, Nobuhiro, Nobuhiko Nakamura, Yuhei Shibata, et al.. (2023). The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 65(3). 339–345. 4 indexed citations
5.
Nakamura, Nobuhiko, Junichi Kitagawa, Takao Miwa, et al.. (2023). A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphoma. Hematological Oncology. 42(1). e3236–e3236. 1 indexed citations
6.
Sakai, Hiroyasu, Takao Miwa, Tatsunori Hanai, et al.. (2020). Development of diffuse large B‑cell lymphoma after sofosbuvir‑ledipasvir treatment for chronic hepatitis C: A case report and literature review. Molecular and Clinical Oncology. 13(3). 1–1. 3 indexed citations
7.
Nakamura, Nobuhiko, Soranobu Ninomiya, Takuro Matsumoto, et al.. (2018). Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia. Annals of Hematology. 98(2). 351–359. 24 indexed citations
8.
Kitagawa, Junichi, Yuhei Shibata, Takuro Matsumoto, et al.. (2016). Efficacy and safety of denosumab in multiple myeloma.. PubMed. 57(5). 592–6.
9.
Nakamura, Nobuhiko, Takeshi Hara, Yuhei Shibata, et al.. (2015). Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Annals of Hematology. 94(12). 2043–2053. 79 indexed citations
10.
Kitagawa, Junichi, Takuro Matsumoto, Yuhei Shibata, et al.. (2015). Efficacy and safety of denosumab for multiple myeloma. Annals of Oncology. 26. vii85–vii85. 1 indexed citations
11.
Hara, Takeshi, Takuro Matsumoto, Yuhei Shibata, et al.. (2015). High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia. Leukemia & lymphoma. 57(1). 92–98. 34 indexed citations
12.
Fukuno, Kenji, Takeshi Hara, Hisashi Tsurumi, et al.. (2014). Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics. Leukemia & lymphoma. 56(5). 1398–1405. 35 indexed citations
13.
Tanaka, Yuki, et al.. (2014). COACHING SKILLS TRAINING FOR PHYSICAL EDUCATION UNIVERSITY STUDENTS WITH E-LEARNING. INTED2014 Proceedings. 611–617. 1 indexed citations
14.
Tsurumi, Hisashi, Takeshi Hara, Naoe Goto, et al.. (2011). A phase II study of rituximab combined with pirarubicin–cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma. Leukemia & lymphoma. 53(2). 247–253. 2 indexed citations
15.
16.
Kitagawa, Junichi, Takeshi Hara, Hisashi Tsurumi, et al.. (2010). Cell Cycle-Dependent Priming Action of Granulocyte Colony-Stimulating Factor (G-CSF) Enhances in vitro Apoptosis Induction by Cytarabine and Etoposide in Leukemia Cell Lines. Journal of Clinical and Experimental Hematopathology. 50(2). 99–105. 13 indexed citations
17.
Goto, Naoe, Takeshi Hara, Hisashi Tsurumi, et al.. (2010). Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies. American Journal of Hematology. 85(11). 872–876. 27 indexed citations
18.
Hara, Takeshi, Hisashi Tsurumi, Senji Kasahara, et al.. (2010). Long-term Survival of a Patient with Splenic Angiosarcoma after Resection, High-dose Chemotherapy, and Autologous Peripheral Blood Stem Cell Transplantation. Internal Medicine. 49(20). 2253–2257. 22 indexed citations
19.
Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP. Journal of Cancer Research and Clinical Oncology. 135(10). 1421–1428. 12 indexed citations
20.
Hara, Takeshi, Hisashi Tsurumi, Naoe Goto, et al.. (2009). Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70 years with diffuse large B cell lymphoma. Journal of Cancer Research and Clinical Oncology. 136(1). 65–70. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Brzeźniakiewicz‐Janus Breakdown of academic impact, for papers by Cemal Beş Breakdown of academic impact, for papers by Kenta Kambara Breakdown of academic impact, for papers by G. Galaktidou Breakdown of academic impact, for papers by Joanna Sulicka‐Grodzicka Breakdown of academic impact, for papers by Luca Riva Breakdown of academic impact, for papers by Tomoka Ao Breakdown of academic impact, for papers by Almudena López‐Sampalo Breakdown of academic impact, for papers by Koushi Yokomura Breakdown of academic impact, for papers by Jenny Valentina Garmendia
Rankless by CCL
2026